Epidemiologia
- MMWR, 18 febbraio 2022 | “Pediatric Emergency Department Visits Before and During the COVID-19 Pandemic — United States, January 2019–January 2022”
- MMWR, 18 febbraio 2022 | “Pediatric Emergency Department Visits Associated with Mental Health Conditions Before and During the COVID-19 Pandemic — United States, January 2019–January 2022”
- eClinicalMedicine , 11 febbraio 2022 | “Which children and young people are at higher risk of severe disease and death after hospitalisation with SARS-CoV-2 infection in children and young people: A systematic review and individual patient meta-analysis”
- The Lancet, 4 febbraio 2022 | “Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden”
- The Lancet, 1 febbraio 2022 | “Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021”
- MMWR, 28 gennaio 2022 | “Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods — United States, December 2020–January 2022”
- ECDC, 20 gennaio 2022 | “Interim analysis of COVID-19 vaccine effectiveness against Severe Acute Respiratory Infection due to laboratory-confirmed SARS-CoV-2 among individuals aged 50 years and older, ECDC multi-country study – first update”
- MMWR, 7 gennaio 2022 | “Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021”
- New England Journal of Medicine , 29 dicembre 2021 | “Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa”
- Nature, 25 novembre 2021 | “SARS-CoV-2 transmission across age groups in France and implications for control”
- Nature Medicine, 11 novembre 2021 | “Deaths in children and young people in England after SARS-CoV-2 infection during the first pandemic year”
- The Lancet infectious Diseases , 29 ottobre 2021 | “Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study”
- The Lancet infectious Diseases , editoriale 29 ottobre 2021| “What is the vaccine effect on reducing transmission in the context of the SARS-CoV-2 delta variant?”
- The Lancet , 8 ottobre 2021 | “Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic”
- The Lancet, editoriale 8 ottobre 2021 | “Depression and anxiety disorders during the COVID-19 pandemic: knowns and unknowns”
- The Lancet Microbe, 29 settembre 2021 | “The role of viral genomics in understanding COVID-19 outbreaks in long-term care facilities”
- New England journal of Medicine, 8 settembre 2021 | “Receipt of mRNA Covid-19 Vaccines and Risk of Spontaneous Abortion”
- MMWR, 3 settembre 2021 | “Trends in COVID-19 Cases, Emergency Department Visits, and Hospital Admissions Among Children and Adolescents Aged 0–17 Years — United States, August 2020–August 2021”
- New England Journal of Medicine, 28 luglio 2021 | “Covid-19 Breakthrough Infections in Vaccinated Health Care Workers”
- New England Journal of Medicine, 22 luglio 2021 | “Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines”
- – BMJ, 14 luglio 2021 | “Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform”
- BMJ, 24 giugno 2021 | “Effect of the covid-19 pandemic in 2020 on life expectancy across populations in the USA and other high income countries: simulations of provisional mortality data”
- The Lancet Infectious Disease, 22 giugno 2021 | “Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study”
- MMWR,11 giugno 2021 | “Genomic Surveillance for SARS-CoV-2 Variants Circulating in the United States, December 2020–May 2021”
- Science, 1 giugno 2021 | “Israel reports link between rare cases of heart inflammation and COVID-19 vaccination in young men”
- JAMA Internal Medicine, 28 maggio 2021 | “Assessment of SARS-CoV-2 Reinfection 1 Year After Primary Infection in a Population in Lombardy, Italy”
- MMWR,25 maggio 2021 | “COVID-19 Vaccine Breakthrough Infections Reported to CDC — United States, January 1–April 30, 2021”
- Science, 25 maggio 2021 | “Estimating infectiousness throughout SARS-CoV-2 infection course”
- The Lancet,22 maggio 2021 | “Patient care and clinical outcomes for patients with COVID-19 infection admitted to African high-care or intensive care units (ACCCOS): a multicentre, prospective, observational cohort study”
- Nature, 11 maggio 2021 | “Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival”
- The Lancet , 23 aprile 2021 | “Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study”
- New England Journal of Medicine, 21 aprile 2021 | “Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons”
- The Lancet Public Health, 21 aprile 2021 | “Mental health and social interactions of older people with physical disabilities in England during the COVID-19 pandemic: a longitudinal cohort study”
- The Lancet Respiratory Medicine, 1 aprile 2021 | “Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study”
- The Lancet Microbe , 23 marzo 2021 | “Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study”
- Istituto Superiore di Sanità, 22 marzo 2021 | “SORVEGLIANZA STRUTTURE RESIDENZIALI SOCIO-SANITARIE NELL’EMERGENZA COVID-19”
- The Lancet, 18 marzo 2021 | “Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study”
- The Lancet, editoriale 18 marzo 2021 | “Sustained neutralising antibodies in the Wuhan population suggest durable protection against SARS-CoV-2”
- BMJ, 18 marzo 2021 | “Association between living with children and outcomes from covid-19: OpenSAFELY cohort study of 12 million adults in England”
- BMJ, 17 marzo 2021| “Clustering and longitudinal change in SARS-CoV-2 seroprevalence in school children in the canton of Zurich, Switzerland: prospective cohort study of 55 schools”
- Annals of Internal Medicine, 16 marzo 2021 | “Antibody Response After SARS-CoV-2 Infection and Implications for Immunity”
- BMJ, 10 marzo 2021 | “Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study”
- JAMA, 10 marzo 2021 | “Association of Age With Likelihood of Developing Symptoms and Critical Disease Among Close Contacts Exposed to Patients With Confirmed SARS-CoV-2 Infection in Italy”
- The Lancet, 10 marzo 2021 | “Children and young people remain at low risk of COVID-19 mortality”
- Annals of Internal Medicine, 9 marzo 2021 | “Clinical and Economic Effects of Widespread Rapid Testing to Decrease SARS-CoV-2 Transmission”
- JAMA, 3 marzo 2021 | “The Potential Future of the COVID-19 PandemicWill SARS-CoV-2 Become a Recurrent Seasonal Infection?”
- MMWR, 26 febbraio 2021 | “Reduction in COVID-19 Patients Requiring Mechanical Ventilation Following Implementation of a National COVID-19 Vaccination Program — Israel, December 2020–February 2021”
- JAMA Internal Medicine, 24 febbraio 2021 | “Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection”
- European Journal of Epidemiology, 15 febbraio 2021 | “COVID-19 mortality in the UK Biobank cohort: revisiting and evaluating risk factors”
- The Lancet Respiratory Medicine , 15 febbraio 2021 | “Patient factors and temporal trends associated with COVID-19 in-hospital mortality in England: an observational study using administrative data”
- New England Journal of Medicine, 13 febbraio 2020 | “The FDA’s Experience with Covid-19 Antibody Tests”
- Environmental Research, 4 febbraio 2021 | “COVID-19 incidence and mortality in Lombardy, Italy: An ecological study on the role of air pollution, meteorological factors, demographic and socioeconomic variables”
- Scienza in Rete, 22 gennaio 2021 | “Le varianti virali: che cosa cambia?”
- Science, 22 gennaio 2021 | “New mutations raise specter of ‘immune escape’”
- JAMA Pediatrics, 22 gennaio 2021 | “Prevalence of SARS-CoV-2 Infection in Children and Their Parents in Southwest Germany”
- JAMA Pediatrics, 22 gennaio 2021 editoriale | “To Spread or Not to Spread SARS-CoV-2—Is That the Question?”
- Annals of Internal Medicine , 22 gennaio 2021 | “The Proportion of SARS-CoV-2 Infections That Are Asymptomatic”
- Istituto Superiore di Sanità, 30 dicembre 2020 | ”Apertura delle scuole e andamento dei casi confermati di SARS-CoV-2: la situazione in Italia”
- New England Journal of Medicine, 23 dicembre 2020 | “Antibody Status and Incidence of SARS- CoV-2 Infection in Health Care Workers”
- JAMA Internal Medicine, 22 dicembre 2020 | “Variation in US Hospital Mortality Rates for Patients Admitted With COVID-19 During the First 6 Months of the Pandemic”
- The Lancet, 13 novembre 2020 | “Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysis”
- Associazione Italiana di Epidemiologia, 28 ottobre 2020 | Test nasofaringeo “antigenico” rapido per il controllo della epidemia: considerazioni, possibili ambiti di applicazione e proposta operativa di gestione
- Nature, 26 ottobre 2020 | Spike mutation D614G alters SARS-CoV-2 fitness
- Annals of Internal Medicine, 21 ottobre 2020 | “COVID-19 Mortality Risk in Down Syndrome: Results From a Cohort Study Of 8 Million Adults”
- Science, 24 settembre 2020 | “Auto-antibodies against type I IFNs in patients with life-threatening COVID-19”
- New England Journal of Medicine, 1 settembre 2020 (editoriale) | “The Power of Antibody-Based Surveillance”
- New England Journal of Medicine, 1 settembre 2020 | “Humoral Immune Response to SARS-CoV-2 in Iceland”
- The Lancet Infectious Diseases, 18 agosto 2020 | “Comparison of molecular testing strategies for COVID-19 control: a mathematical modelling study”
- Annals of Internal Medicine, 12 agosto 2020 | “Obesity and Mortality Among Patients Diagnosed With COVID-19: Results From an Integrated Health Care Organization”
- Annals of Internal Medicine, 22 luglio 2020 | “The Contribution of the Age Distribution of Cases to COVID-19 Case Fatality Across Countries”
- Science, 17 luglio 2020 | “Assessing the impact of coordinated COVID-19 exit strategies across Europe”
- NEJM Journal Watch, 14 luglio 2020 | “Risk Factors for Death from COVID-19 in a Cohort of 17 Million People”
- JAMA Internal Medicine, 1 luglio 2020 | “Estimation of Excess Deaths Associated With the COVID-19 Pandemic in the United States, March to May 2020”
- Nature /accelerated article prewiew, 1 luglio 2020 | “OpenSAFELY: factors associated with COVID-19 death in 17 million patients”
- Istituto Superiore di Sanità, 10 luglio 2020 | “IMPATTO DELL’EPIDEMIA COVID-19 SULLA MORTALITÀ TOTALE DELLA POPOLAZIONE RESIDENTE PERIODO GENNAIO-MAGGIO 2020”
- The Lancet, 6 luglio 2020 | “Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study”
- Journal of Nephrology, 3 luglio 2020 | “Exposure to novel coronavirus in patients on renal replacement therapy during the exponential phase of COVID-19 pandemic: survey of the Italian Society of Nephrology”
- Int. J. Environ. Res. Public Health, 2 luglio 2020 | “Effects of Covid-19 Lockdown on Mental Health and Sleep Disturbances in Italy”
- Morbidity and Mortality Weekly Report (MMWR), 1 luglio 2020 | “Initial and Repeated Point Prevalence Surveys to Inform SARS-CoV-2 Infection Prevention in 26 Skilled Nursing Facilities — Detroit, Michigan, March–May 2020”
- Nature, 16 giugno 2020 | “How deadly is the coronavirus? Scientists are close to an answer”
- The Lancet , 11 giugno 2020 | “Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study”
- Clinical Infetious Diseases, 4 giugno 2020 | “The natural history and transmission potential of asymptomatic SARS-CoV-2 infection”
- BMJ, 22 maggio 2020 | “Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study”
- Scienza in rete, 25 maggio 2020 | Perché si muore sempre meno di Covid?
- New England Journal of Medicine, 21 maggio 2020 | “Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington”
- New England Journal of Medicine, 15 maggio | Wrong but Useful – What Covid-19 Epidemiologic Models Can and Cannot Tell Us
- New England Journal of Medicine, 1 maggio 2020 | Children with Covid-19 in Pediatric Emergency Departments in Italy
- Nature Medicine, 22 aprile 2020 | Modelling the COVID-19 epidemic and implementation of population-wide interventions in Italy
- Nature Medicine, 22 aprile 2020 | Modelling the COVID-19 epidemic and implementation of population-wide interventions in Italy
- European Journal of Epidemiology , 18 aprile 2020 | ”Covid-19 epidemic in Italy: evolution, projections and impact of government measures”
- Science, 14 aprile 2020, | Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period
- Istituto Superiore di Sanità, aggiornamento 14 aprile 2020 | “Survey nazionale sul contagio COVID-19 nelle strutture residenziali e sociosanitarie”
- Acta Biomed, 8 aprile 2020 | “COVID-19 in Italy: impact of containment measures and prevalence estimates of infection in the general population”
- JAMA, 7 aprile 2020 | “Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention”
- BMJ, 7 aprile 2020 | “Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal”
- MMWR, 6 aprile 2020 | “Coronavirus Disease 2019 in Children — United States, February 12–April 2, 2020”
- JAMA, 6 aprile 2020 | “Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS- CoV-2 Admitted to ICUs of the Lombardy Region, Italy”
- The Lancet, 4 aprile | “ Developing antibody tests for SARS-CoV-2”
- NEW England Journal of Medicine , 26 marzo 2020 | “Defining the Epidemiology of Covid-19 — Studies Needed”
- The Lancet Public Health , 25 marzo 2020 | “The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study”
- JAMA, 23 Marzo 2020 | Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy
- Uno studio dei ricercatori FBK 20 Marzo 2020 | “The early phase of the COVID-19 outbreak in Lombardy, Italy” pubblicato sull’archivio pubblico “Arxiv”